Sharp increase in the number of patients, revenues and earnings
Asklepios finished FY2010 on a high note, reporting strong growth in all its key performance indicators (KPIs). The dynamic development of one of the largest privately managed clinic operators in Germany continued despite a challenging overall economic climate. The clinic group’s revenues increased 6.6% to EUR 2,305 million (2009: EUR 2,163 million) on the back of a 6.5% rise in the number of patients treated. EBITDA soared over 15%, driven by efficiency improvements and other process optimization measures.
Dr. Tobias Kaltenbach, Chairman of the Asklepios Group management board, said “The excellent developments in fiscal 2010 follow on the heels of a very successful 2009. The increased number of patients clearly confirmed our broad strategy. New and attractive high-quality medical offers and state-of-the-art processes for in-patient treatment enabled us once again to generate strong growth.” Group CFO Stephan Leonhard added: “We succeeded in beating our ambitious growth and income targets in almost every area. In doing so, the performance of our Hamburg clinics in fiscal 2010 was particularly prominent, standing out as one of the most successful business years in our corporate history.”
Laborgesellschaft
